Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 454-459

  De La Cruz, J P ^a   Moreno, A ^a   Munoz M ^a   Campos, J M Garcí ^a   De La Cuesta, F Sánchez ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; ERYTHROCYTE DEFORMABILITY; EXPERIMENTAL DIABETES MELLITUS; GLYCOSYLATION; MICROANGIOPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA BLOOD VESSEL; STREPTOZOCIN DIABETES; THROMBOCYTE AGGREGATION;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ASPIRIN; DIABETES MELLITUS, EXPERIMENTAL; DIPYRIDAMOLE; EPOPROSTENOL; MALE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; STREPTOZOCIN;

EID: 0030942183     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. CARDINAL, D. C. AND FLOWER, R. J.: The electronic aggregometer: A novel device for assessing platelet behavior in blood. J. Pharm. Meth. 3: 135-158, 1980.
2. CARTER, A. J. AND HANLEY, S. P.: The effect of platelet number and haematocrit on whole blood thromboxane synthesis. Thromb. Haemostas. 54: 225-227, 1985.
3. DALLINGER, K., JENNINGS, P., TOOP, M., GYDE, O. AND BARNETT, A.: Platelet aggregation and coagulation factors in insulin dependent diabetics with and without microangiopathy. Diabetic Med. 4: 44-48, 1987.
4. DE LA CRUZ, J. P., BELLIDO, I., CAMARA, S., MARTOS, F. AND SANCHEZ DE LA CUESTA, F.: Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood: An "in vitro" study. Scand. J. Haematol. 36: 394-397, 1986.
5. DE LA CRUZ, J. P., MORENO, A., GARCÍA CAMPOS, J. M. AND SÁNCHEZ DE LA CUESTA, F.: infiuencia de la modificacion farmacológica del equilibrio tromboxano/prostaciclina sobre la retinopatía diabética experimental. Rev. Iberoamer. Comb. Hemostas. VII: 1-6, 1994.
6. DE LA CRUZ, J. P., MORENO, A., SANCHEZ DE LA CUESTA, F. AND GARCÍA CAMPOS, J. M.: Effect of antiplatelet drug therapy on the retinal vascular pattern in experimental diabetes mellitus. Can. J. Ophthalmol. 25: 329-332, 1990.
7. D'ERASMO, E. AND ACCA, M.: Platelet size changes after myocardial infarction. Lancet 339: 738-739, 1992.
8. ENGERMAN, R. I.: Pathogenesis of diabetic retinopathy. Diabetes 38: 1203-1206, 1989.
9. ESMATJES, E., MASERAS, M., GALLEGO, M., COVES, M. AND CONGET, I.: Effect of the "treatment with an inhibitor of platelet aggregation on the evolution of background retinopathy: 2 years of follow-up. Diabetes Res. Clin. Pract. 7: 286-291, 1989.
10. EUROPEAN STROKE PREVENTION STUDY GROUP. European Stroke Prevention Study. Stroke 21: 1122-1130, 1990.
11. GONZALEZ, D. AND WINTZ, A.: Digital Image Processing. Addison-Wesley Publishing Company. London. 1987.
12. ISHII, H., UMEDA, F. AND NAWATA, H.: Platelet function in diabetes mellitus. Diabetes Metab. Rev. 8: 53-66, 1992.
13. KALTER-LEIBOVICI, O., VAN DYK, D. AND LEIBOVICI, L.: Risk factors for the development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes 40: 204-210, 1991.
14. KINSELLA, D., TROUP, W. AND MCGREGOR, M.: Studies with a new coronary vasodilator drug: Persantin. Am. Heart J. 141-145, 1962.
15. KOHNER, E., PATEL, V. AND RASSAM, S. M.: Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44: 603-607, 1995.
16. MERIMEE, T. J.: Diabetic retinopathy. A synthesis of perspectives. N. Engl. J. Med. 322: 978-983, 1990.
17. MESULAM, M.: Tracing Neural Connections with Horseradish Peroxidase. Wiley Interscience, Boston, 1982.
18. 2 interactions in haemostasis And thrombosis. Haemostasis 8: 252-265, 1979.
19. MONCADA, S., HIGGS, E. AND VANE, J. R.: Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1: 18-20, 1977.
20. MORENO, A., DE LA CRUZ, J. P., GARCIA CAMPOS, J. M. AND SANCHEZ DE LA CUESTA, F.: Hyperactivity of platelet function in human diabetes mellitus is different according to the type of retinopathy. Vis. Res. 35: P334, 1995a.
21. MORENO, A., DE LA CRUZ, J. P., GARCÍA CAMPOS, J. AND SÁNCHEZ DE LA CUESTA, F.: Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes. Can. J. Ophthalmol. 30: 117-123, 1995c.
22. MORENO, A., DE LA CRUZ, J. P., MÉRIDA, F., GARCÍA CAMPOS, J. AND SÁNCHEZ DE LA CUESTA, F.: Effects of ditazol on the vascular retinal pattern in experimental diabetes. Haemostasis 25: 166-171, 1995b.
23. OSTERMANN, H. AND VAN DE LOO, J.: Factors of the hemostatic system in diabetic patients. A survey of controlled studies. Haemostasis 16: 386-416, 1986.
24. PAGANI, A., GRECO, G., TAGLIAFERRO, V., MARENA, S. AND PAGANO, G.: Dipyridamole administration in insulin-dependent diabetics with background retinopathy: A 36-month follow-up. Curr. Ther. Res. 45: 469-175, 1989.
25. PERSANTINE-ASPIRIN REINFARCTION STUDY (PARIS) RESEARCH GROUP. Secondary coronary prevention with persantine and aspirin (Part II). J. Am. Coll. Cardiol. 7: 251-269, 1986.
26. SAMUELSSON, B., GOLDYNE, M. AND GRANSTROM, E.: Prostaglandins and thromboxanes. Ann. Rev. Biochem. 47: 997-1029, 1978.
27. THE DAMAD STUDY GROUP (DAMAD): Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. Diabetes 38: 491-498, 1989.
28. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP (DCCTRG): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
29. THE TIMAD STUDY GROUP (TIMAD): Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. Arch. Ophthalmol. 108: 1577-1583, 1990.